The present invention relates to novel pyrimidone derivatives of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly provides novel pyrimidone derivatives of the general formula (I) and a method thereof.
1
本发明涉及一般式(I)的新型
嘧啶酮衍
生物,它们的衍
生物、类似物、互变异构体、立体异构体、多晶形态、
水合物、溶剂合物、药学上可接受的盐以及含有它们的药学上可接受的组合物。本发明更具体地提供了一般式(I)的新型
嘧啶酮衍
生物及其制备方法。